Efficacy of Parecoxib on Patients With CRPS
Expanded access is no longer available for this treatment.
Ruhr University of Bochum
First Posted: February 1, 2012
Last Update Posted: April 25, 2012
Information provided by (Responsible Party):
Christoph Maier, Ruhr University of Bochum
The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.
|Study Type:||Expanded Access What is Expanded Access?|
|Official Title:||Efficiacy of the Selctive COX-2-inhibitor Parecoxibe on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS)|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Christoph Maier, Ruhr University of Bochum:
Contacts and Locations
No Contacts or Locations Provided